Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $54.87 million. The enterprise value is $34.66 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.44 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 16.44M |
| Shares Outstanding | 16.44M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 16.61% |
| Owned by Institutions (%) | 28.35% |
| Float | 13.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 88.00 |
| PS Ratio | 1.49 |
| Forward PS | 1.16 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | 16.10 |
| P/OCF Ratio | 15.77 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 9.92 |
Financial Position
The company has a current ratio of 8.14, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.14 |
| Quick Ratio | 5.42 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.62% and return on invested capital (ROIC) is -1.61%.
| Return on Equity (ROE) | -1.62% |
| Return on Assets (ROA) | -1.46% |
| Return on Invested Capital (ROIC) | -1.61% |
| Return on Capital Employed (ROCE) | -2.61% |
| Revenue Per Employee | $695,630 |
| Profits Per Employee | -$15,704 |
| Employee Count | 54 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, SRTS has paid $356,000 in taxes.
| Income Tax | 356,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.66% in the last 52 weeks. The beta is 1.35, so SRTS's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -43.66% |
| 50-Day Moving Average | 4.75 |
| 200-Day Moving Average | 5.72 |
| Relative Strength Index (RSI) | 31.53 |
| Average Volume (20 Days) | 243,173 |
Short Selling Information
The latest short interest is 824,743, so 5.02% of the outstanding shares have been sold short.
| Short Interest | 824,743 |
| Short Previous Month | 807,049 |
| Short % of Shares Out | 5.02% |
| Short % of Float | 6.02% |
| Short Ratio (days to cover) | 7.59 |
Income Statement
In the last 12 months, SRTS had revenue of $37.56 million and -$848,000 in losses. Loss per share was -$0.05.
| Revenue | 37.56M |
| Gross Profit | 19.60M |
| Operating Income | -1.37M |
| Pretax Income | 6.45M |
| Net Income | -848,000 |
| EBITDA | -1.05M |
| EBIT | -1.37M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $22.16 million in cash and $595,000 in debt, giving a net cash position of $21.57 million or $1.31 per share.
| Cash & Cash Equivalents | 22.16M |
| Total Debt | 595,000 |
| Net Cash | 21.57M |
| Net Cash Per Share | $1.31 |
| Equity (Book Value) | 52.06M |
| Book Value Per Share | 3.17 |
| Working Capital | 45.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.57 million and capital expenditures -$74,000, giving a free cash flow of $3.49 million.
| Operating Cash Flow | 3.57M |
| Capital Expenditures | -74,000 |
| Free Cash Flow | 3.49M |
| FCF Per Share | $0.21 |
Full Cash Flow StatementMargins
Gross margin is 52.18%, with operating and profit margins of -3.64% and -2.26%.
| Gross Margin | 52.18% |
| Operating Margin | -3.64% |
| Pretax Margin | -1.31% |
| Profit Margin | -2.26% |
| EBITDA Margin | -2.78% |
| EBIT Margin | -3.64% |
| FCF Margin | 9.30% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -1.51% |
| FCF Yield | 6.21% |
Analyst Forecast
The average price target for SRTS is $8.00, which is 139.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 139.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 12.66% |
| EPS Growth Forecast (5Y) | -5.57% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 10.42 and a Piotroski F-Score of 2.
| Altman Z-Score | 10.42 |
| Piotroski F-Score | 2 |